Since 1995, the FDA has cleared 521 artificial intelligence-enabled medical devices through 510(k) clearance, de novo requests or approved premarket approval applications.
Tallahassee-based Florida State University has entered a scientific collaboration with Lento Bio, a pharmaceutical company developing medications for presbyopia.
Bronson Healthcare, based in Kalamazoo, Mich., and behavioral health provider Acadia Healthcare, based in Franklin, Tenn., have named the inaugural CEO to their joint-venture behavioral health hospital.
Christine Schuster, the president and CEO of Concord, Mass.-based Emerson Health, has been named the 82nd chair of the Massachusetts Health and Hospital Association’s board of trustees, according to The Sun.
A Florida nursing home administrator is on trial for the overheating deaths of nine patients after Hurricane Irma in 2017 in what his attorney calls a “scapegoat” case, ABC News reported Feb. 6.
Troubled West Reading, Pa.-based Tower Health, which is currently undergoing a strategic review and selling off several assets, suffered a rating downgrade on its bonds, S&P Global reported Feb. 6, adding that the outlook is negative.
“Mmm hmm.” “Uh-uh.” When your physician answers your questions with those phrases, you understand. But the artificial intelligence listening to your conversation might not.